Tobacco use is the leading preventable cause of death in the US and a major driver of health disparities. Among our tools for reducing the harms of tobacco is lung cancer screening (LCS). This study will combine a review of existing qualitative and quantitative data on barriers to lung cancer screening and smoking cessation in underserved populations, a quantitative analysis of predictors of lung cancer screening and smoking cessation treatment use among Massachusetts Federally Qualified Health Centers (FQHC)s, and a stakeholder advisory group to synthesize these data and select implementation strategies that reflects the critical determinants and the strengths and resource constraints of the Federally Qualified Health Centers (FQHC) context.
Aim 1) To design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke. Aim 2) To assess the acceptability, appropriateness and feasibility of the implementation strategy among community health center staff.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
9
One time interview, 60-90 minutes
The team will meet with the stakeholder advisory group four times for 1-2 hours each
Massacusetts General Hospital
Boston, Massachusetts, United States
Feasibility of Intervention Measure
Feasibility of Intervention Measure, 5-point Likert scales (range 1-5), higher values reflect favorable outcomes
Time frame: End of study, up to 16 weeks
Acceptability of Intervention Measure
Acceptability of Intervention Measure, 5-point Likert scales (range 1-5), higher values reflect favorable outcomes
Time frame: End of study, up to 16 weeks
Intervention Appropriateness Measure
Intervention appropriateness measure, 5-point Likert scales (range 1-5), higher values reflect favorable outcomes
Time frame: End of study, up to 16 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.